![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 45/06 | |
A61K 31/437 | |||
A61K 31/4985 | |||
A61K 31/517 | |||
A61K 31/519 | |||
A61K 31/52 | |||
A61K 31/522 | |||
A61K 31/53 | |||
A61K 31/706 | |||
A61P 35/00 |
(11) | Patento numeris | 2817029 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13707520.6 |
Europos patento paraiškos padavimo data | 2013-02-22 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-12-31 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-10 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2013/027235 |
Data | 2013-02-22 |
(87) | Numeris | WO 2013/126636 |
Data | 2013-08-29 |
(30) | Numeris | Data | Šalis |
201261603012 P | 2012-02-24 | US | |
201261716424 P | 2012-10-19 | US | |
201261725805 P | 2012-11-13 | US |
(72) |
XU, Shuichan, US
HEGE, Kristen, Mae, US
TRAN, Tam, Minh, US
|
(73) |
Signal Pharmaceuticals, LLC,
10300 Campus Point Drive Suite 100, San Diego, CA 92121,
US
|
(54) | METHODS FOR TREATING NON-SMALL CELL LUNG CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY |
METHODS FOR TREATING NON-SMALL CELL LUNG CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY |